Irinotecan (CPT-11), oxaliplatin (OHP), and raltitrexed every two weeks in untreated metastatic colorectal cancer (CRC) patients

Irinotecan (CPT-11), oxaliplatin (OHP), and raltitrexed every two weeks in untreated metastatic colorectal cancer (CRC) patients (2002)

Authors:
Autor USP: CUTAIT, RAUL - FM
Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS; METÁSTASE NEOPLÁSICA
Language: Inglês
Imprenta:
- Publisher place: Orlando
- Date published: 2002
Source:
- Título do periódico: American Society of Clinical Oncology
- Volume/Número/Paginação/Ano: v. 21, part 2 of 2, p. 134b, res. 2348, 2002
Conference titles: Annual Meeting the American Society of Clinical Oncology

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

COSTA, F. P. et al. Irinotecan (CPT-11), oxaliplatin (OHP), and raltitrexed every two weeks in untreated metastatic colorectal cancer (CRC) patients. American Society of Clinical Oncology. Orlando: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2002
APA

Costa, F. P., Marques, R. J., Mayer, I. A., Maluf, F. C., Martins, S. C., Cutait, R., & Buzaid, A. C. (2002). Irinotecan (CPT-11), oxaliplatin (OHP), and raltitrexed every two weeks in untreated metastatic colorectal cancer (CRC) patients. American Society of Clinical Oncology. Orlando: Faculdade de Medicina, Universidade de São Paulo.
NLM

Costa FP, Marques RJ, Mayer IA, Maluf FC, Martins SC, Cutait R, Buzaid AC. Irinotecan (CPT-11), oxaliplatin (OHP), and raltitrexed every two weeks in untreated metastatic colorectal cancer (CRC) patients. American Society of Clinical Oncology. 2002 ; 21 134b.[citado 2024 abr. 24 ]
Vancouver

Costa FP, Marques RJ, Mayer IA, Maluf FC, Martins SC, Cutait R, Buzaid AC. Irinotecan (CPT-11), oxaliplatin (OHP), and raltitrexed every two weeks in untreated metastatic colorectal cancer (CRC) patients. American Society of Clinical Oncology. 2002 ; 21 134b.[citado 2024 abr. 24 ]